Evidence map›Paper›PMID 20662742›Full record

ReviewExpert opinion on biological therapy2010

Gene therapy as future treatment of erectile dysfunction.

Naoki Yoshimura, Ryuichi Kato, Michael B Chancellor, Joel B Nelson, Joseph C Glorioso

Abstract readReview
In one paragraph

Review in Expert opinion on biological therapy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Erectile preservation following radical prostatectomy.Therapeutic advances in urology · 2011
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Naoki YoshimuraUniversity of Pittsburgh School of Medicine, Department of Urology, Suite 700 Kaufmann Medical Building, 3471 Fifth Avenue, Pittsburgh, PA 15213, USA. nyos@pitt.edu
Ryuichi Kato
Michael B Chancellor
Joel B Nelson
Joseph C Glorioso
University of Pittsburgh · USBeaumont Hospital, Royal Oak · USUniversity of Pittsburgh Medical Center · USWeatherford College · US

Funding

Targeting HSV vectorsU01HL066949 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LONDON, BARRY · 2000 to 2005
$20.8M
PRE-CLINICAL VECTOR PRODUCTIONP01DK044935 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GOINS, WILLIAM F. · 1993 to 2010
$11.8M
Preclinical Gene Therapy in a Large Animal Model of DMDU54AR050733 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GLORIOSO, JOSEPH C · 2003 to 2008
$7.7M
Glioma Therapy Using Targeted Oncolytic HSV VectorsR01CA119298 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GLORIOSO, JOSEPH C · 2006 to 2010
$1.8M
NCI NIH HHS CA119298NCI NIH HHS R01 CA119298NHLBI NIH HHS HL066949NHLBI NIH HHS U01 HL066949NIAMS NIH HHS AR050733NIAMS NIH HHS U54 AR050733NIDDK NIH HHS DK044935NIDDK NIH HHS P01 DK044935PHS HHS MS040923
6 · The paper itself

Abstract

importance of the fieldErectile dysfunction (ED) is a major men's health problem. Although the high success rate of treating ED by phosphodiesterase 5 (PDE5) inhibitors has been reported, there are a significant number of ED patients who do not respond to currently available treatment modalities. AREAS COVERED IN THIS REVIEW: To elucidate the current status of gene therapy applications for ED, gene therapy approaches for ED treatment are reviewed. WHAT THE READER WILL GAIN: Gene therapy strategies that can enhance nitric oxide (NO) production or NO-mediated signaling pathways, growth factor-mediated nerve regeneration or K(+) channel activity in the smooth muscle could be promising approaches for the treatment of ED. Although the majority of gene therapy studies are still in the preclinical phase, the first clinical trial using non-viral gene transfer of Ca(2+)-activated, large-conductance K(+) channels into the corpus cavernosum of ED patients showed positive results. TAKE HOME MESSAGE: Gene therapy represents an exciting future treatment option for ED, especially for people with severe ED unresponsive to current first-line therapies such as PDE5 inhibitors although the long-term safety of both viral and non-viral gene therapies should be established.

Indexed as

Genetic TherapyPenile ErectionAnimalsErectile DysfunctionGenetic VectorsGene Transfer TechniquesHumansIntercellular Signaling Peptides and ProteinsMaleNitric OxidePenisPotassium ChannelsSignal TransductionTreatment OutcomeIntercellular Signaling Peptides and ProteinsNitric OxidePotassium Channels

Identifiers

PMID20662742
PMCPMC3064945
OpenAlexW2031897881

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.